Medications for Bloating
For functional bloating in adults, antispasmodics are the first-line pharmacological option, with rifaximin as an effective alternative, particularly when small intestinal bacterial overgrowth is suspected, and secretagogues (linaclotide, lubiprostone, plecanatide) reserved for bloating associated with constipation. 1
First-Line Pharmacological Approach
Antispasmodics
Antispasmodics represent the most accessible and evidence-supported initial medication choice for bloating. A meta-analysis of 26 RCTs with 2,811 patients demonstrated that antispasmodics reduced persistent global symptoms and abdominal pain (RR 0.65; 95% CI 0.56 to 0.76) 1. These agents work by:
- Antimuscarinics (dicycloverine, hyoscine butylbromide, otilonium bromide): Reduce intestinal motility
- Smooth muscle relaxants (alverine, mebeverine, peppermint oil): Directly relax intestinal smooth muscle
Common pitfall: Abdominal pain, bloating, nausea, and constipation are frequent side effects with antimuscarinics. Start with low doses and titrate carefully to improve tolerability 1.
Rifaximin
Rifaximin, a non-absorbable antibiotic, shows significant efficacy specifically for bloating symptoms. Meta-analysis data demonstrates:
- 44.6% improvement vs 34.6% with placebo (RR 1.22; 95% CI 1.11-1.35) 2
- Critical dosing detail: Daily doses must be ≥1200 mg/day to be effective; lower doses show no benefit over placebo 2
- Standard regimen: 550 mg three times daily for 14 days 3
Rifaximin is particularly valuable when dysbiosis or small intestinal bacterial overgrowth contributes to bloating 4, 5.
Second-Line Options for Bloating with Constipation
When bloating occurs alongside constipation (IBS-C pattern), secretagogues demonstrate superior efficacy:
Secretagogues (in order of efficacy for bloating)
- Linaclotide 290 µg once daily: Most efficacious agent for bloating in IBS-C (RR 0.78; 95% CI 0.74-0.83, NNT=7, P-score 0.97) 6
- Lubiprostone 8 µg twice daily: Effective for both constipation and bloating 7, 6
- Plecanatide: Similar efficacy to other secretagogues 7
- Tenapanor 50 mg twice daily: Sodium-hydrogen exchanger-3 inhibitor, effective for IBS-C bloating 7, 6
All secretagogues were superior to placebo in a meta-analysis of 13 trials, with no significant differences between agents in indirect comparisons 7.
Neuromodulators for Refractory Cases
Tricyclic Antidepressants (TCAs)
TCAs modify gut motility and alter visceral nerve responses beyond their antidepressant effects 8, 4:
- Start with low doses (10-25 mg at bedtime) and titrate gradually
- Normalize rapid small bowel transit in diarrhea-predominant patterns
- Caution: Avoid in patients at risk for QT prolongation; constipation is the most significant side effect 8
Other Neuromodulators
- SNRIs, mirtazapine, buspirone: May be considered for functional bloating, particularly with psychological comorbidity 9, 4
- SSRIs: Not recommended as they show no improvement in global symptoms or abdominal pain 8
Probiotics
Probiotics may be considered as adjunctive therapy for functional bloating 10, 4, 5. Recent evidence suggests:
- Lactobacillus helveticus showed significant improvement in bloating sensation and visible distension 11
- Restoring balanced microbiome appears promising for FAB/FAD management 5
- Quality of evidence remains variable; select specific strains with documented efficacy
Algorithmic Treatment Approach
Step 1: Start with antispasmodics (otilonium bromide, peppermint oil, or hyoscine butylbromide) for isolated bloating
Step 2: If bloating persists after 4 weeks OR if constipation is present:
- With constipation: Switch to linaclotide 290 µg daily (first choice) or alternative secretagogue
- Without constipation: Add rifaximin 550 mg TID for 14 days (ensure ≥1200 mg/day total dose)
Step 3: For refractory symptoms after 8-12 weeks:
- Add low-dose TCA (amitriptyline 10-25 mg at bedtime)
- Consider probiotics as adjunctive therapy
- Refer for brain-gut behavioral therapies (CBT, hypnotherapy) 7, 4
Critical Caveats
- Exclude organic disease first: Rule out inflammatory activity, structural complications, bile acid diarrhea, small intestinal bacterial overgrowth, and carbohydrate intolerance before diagnosing functional bloating 10
- Avoid opiates: These worsen bloating and should never be used for functional GI symptoms 10
- Dietary modification precedes medication: Low FODMAP diet supervised by a dietitian should be implemented alongside pharmacotherapy 1, 4
- Soluble fiber caution: Start at 3-4 g/day and build gradually; insoluble fiber (wheat bran) may exacerbate bloating 1